Chairperson's Perspective: Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
Darren Brenner, MD
Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
Neal Shore, MD, FACS
Sarah Psutka, MD, MS
What’s New In Glaucoma?
Paul Petrakos, DO, MS
Justin Schweitzer, OD, FAAO
I. Paul Singh, MD
Sarah H. Van Tassel, MD
SunRISe-1: 1-Year Durability and Patient-Reported Outcomes Results
First Results From Cohort 4 of the SunRISe-1 Trial
Ocular to Generalized MG: How and Why the Disease Evolves
Vera Bril, MD
Hans Katzberg, MD
Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
Jonathan Strober, MD
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
Nicholas J. Silvestri, MD
Collaborative Insights to Solve the Puzzle of Bladder Cancer
Daniel P. Petrylak, MD
Elizabeth R. Plimack, MD, MS, FASCO
Evan Y. Yu, MD
What’s New in Glaucoma Therapy?
What’s New in Subconjunctival MIBS
What’s New in Suprachoroidal MIGS?
What’s New in Glaucoma Topical Therapies?
New Solutions for Optimizing IOP Control: A Case-Based Approach
What’s New With 3D Visualization in Glaucoma Surgery?
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.